首页> 外文期刊>Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis >Molecular characterization of 7 patients affected by dys- or hypo-dysfibrinogenemia: Identification of a novel mutation in the fibrinogen Bbeta chain causing a gain of glycosylation
【24h】

Molecular characterization of 7 patients affected by dys- or hypo-dysfibrinogenemia: Identification of a novel mutation in the fibrinogen Bbeta chain causing a gain of glycosylation

机译:7名受血纤维蛋白原异常或低血纤维蛋白原异常影响的患者的分子特征:鉴定纤维蛋白原Bbeta链中导致糖基化增加的新突变

获取原文
获取原文并翻译 | 示例
           

摘要

Fibrinogen is a hexameric glycoprotein consisting of two sets of three polypeptides (the A alpha, B beta, and. chains, encoded by the three genes FGA, FGB, and FGG). It is involved in the final phase of the coagulation process, being the precursor of the fibrin monomers necessary for the formation of the hemostatic plug. Rare inherited fibrinogen disorders can manifest as quantitative deficiencies, qualitative defects, or both. In particular, dysfibrinogenemia and hypo-dysfibrinogenemia are characterized by reduced functional activity associated with normal or reduced antigen levels, and are usually determined by heterozygous mutations affecting any of the three fibrinogen genes.
机译:纤维蛋白原是一种六聚体糖蛋白,由两组三个多肽组成(A alpha,B beta和链,由三个基因FGA,FGB和FGG编码)。它参与凝血过程的最后阶段,是形成止血栓所必需的纤维蛋白单体的前体。罕见的遗传性纤维蛋白原疾病可表现为定量缺陷,定性缺陷或两者兼而有之。特别地,血纤维蛋白原血症和血纤维蛋白原低血症的特征在于与正常水平或抗原水平降低相关的功能活性降低,并且通常由影响三种血纤蛋白原基因中任何一个的杂合突变确定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号